Inventor
JIANG SHIBO
CN30 patents
⚠️ This page may combine multiple inventors who share the name “JIANG SHIBO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEW YORK BLOOD CENTER INC
11 patentsUS5444044AAug 22, 1995
Synthetic polypeptides as inhibitors of HIV-1
NEW YORK BLOOD CENTER INC48 citations95
US5985275ANov 16, 1999
β-Lactoglobulin modified with aromatic anhydride compound for preventing HIV infection
NEW YORK BLOOD CENTER INC22 citations92
US5952009ASep 14, 1999
Methods for preventing the transmission of or treating patients infected with herpesvirus
NEW YORK BLOOD CENTER INC21 citations92
US5840843ANov 24, 1998
Synthetic polypeptides as inhibitors of HIV-1
NEW YORK BLOOD CENTER INC40 citations92
US5985313ANov 16, 1999
Method for decreasing the frequency of transmission of viral infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients
NEW YORK BLOOD CENTER INC26 citations91
US5798206AAug 25, 1998
Methods for screening of test compounds for inhibiting binding of a CD4-HIV 1 complex to a chemokine receptor
NEW YORK BLOOD CENTER INC25 citations89
US9889194B2Feb 13, 2018
Immunogenic composition for MERS coronavirus infection
NEW YORK BLOOD CENTER INC12 citations81
US11103575B2Aug 31, 2021
Immunogenic composition for MERS coronavirus infection
NEW YORK BLOOD CENTER INC0 citations60
US9943589B2Apr 17, 2018
Immunopotentiator-linked oligomeric influenza immunogenic compositions
NEW YORK BLOOD CENTER INC0 citations50
US9724383B2Aug 8, 2017
Stabilized trimeric HIV-1 GP41 fusion inhibitor polypeptides comprising the N-terminal heptad repeat (NHR) and foldon (FD) trimerization motif
NEW YORK BLOOD CENTER INC0 citations49
US9701736B2Jul 11, 2017
Influenza hemagglutinin-specific monoclonal antibodies for preventing and treating influenza virus infection
NEW YORK BLOOD CENTER INC1 citations49
NEW YORK BLOOD CT INC
6 patentsUS6165493ADec 26, 2000
"Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections"
NEW YORK BLOOD CT INC77 citations94
US6596497B1Jul 22, 2003
Screening of antiviral compounds targeted to the HIV-1 gp41 core structure
NEW YORK BLOOD CT INC63 citations91
US6727240B1Apr 27, 2004
Methods for preventing HIV-1 or HIV-2 infection
NEW YORK BLOOD CT INC10 citations73
US7241803B2Jul 10, 2007
Compounds for inhibition of HIV infection by blocking HIV entry
NEW YORK BLOOD CT INC4 citations62
US7629443B2Dec 8, 2009
Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus
NEW YORK BLOOD CT INC3 citations57
US7919101B2Apr 5, 2011
Highly potent synergistic combinations of human immunodeficiency virus (HIV) fusion inhibitors
NEW YORK BLOOD CT INC0 citations50
JIANG SHIBO
6 patentsUS8828931B2Sep 9, 2014
Bifunctional molecules for inhibiting HIV entry
JIANG SHIBO3 citations59
US8900585B2Dec 2, 2014
Influenza hemagglutinin-specific monoclonal antibodies for preventing and treating influenza virus infection
JIANG SHIBO2 citations58
US8936789B2Jan 20, 2015
Immunoenhancer-linked oligomeric HIV envelope peptides
JIANG SHIBO3 citations57
US8828932B2Sep 9, 2014
Bifunctional molecules for inactivating HIV and blocking HIV entry
JIANG SHIBO0 citations50
US9592287B2Mar 14, 2017
Immunopotentiator-linked oligomeric influenza immunogenic compositions
JIANG SHIBO0 citations49
US9115186B2Aug 25, 2015
Stabilized trimeric HIV-1 gp41 fusion polypeptides comprising the N-terminal heptad repeat (NHR) and foldon (FD) trimerization motif
JIANG SHIBO1 citations48
XIE LAN
2 patentsUS8933106B2Jan 13, 2015
2-(4-substituted phenylamino) polysubstituted pyridine compounds as inhibitors of non-nucleoside HIV reverse transcriptase, preparation methods and uses thereof
XIE LAN1 citations45
US8309602B2Nov 13, 2012
Multi-substituted diarylanilines as non-nucleoside HIV reverse transcriptase inhibitors, and preparation and use thereof
XIE LAN0 citations34